L3VLUP
ProSign in

ANGO in the 13F filings

Angiodynamics Inc · CUSIP 03475V101

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2024
the date the book describes
Filed
13 Aug 2024
latest of these filings; the earliest 12 Aug 2024
Managers listing it
2
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 0 listed it in both
Shares listed
1,236,203
combined, among listed positions
Reported value
$7.5m
combined, at the quarter end

Among the 94 comparable managers: 2 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing ANGO in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

2 of 2 holders

ActionFiling
ExodusPoint Capital Management LP1,017,834$6.2munder 0.1%Addedn.a.13 Aug 2024 (the filing on sec.gov)
First Eagle Investment Management LLC218,369$1.3munder 0.1%Newnew12 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

01232017201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ANGO by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20161$971kn.a.n.a.
Q4 20161$9.0mn.a.n.a.
Q1 20171$6.7mn.a.n.a.
Q2 20173$9.0mn.a.n.a.
Q1 20181$12mn.a.n.a.
Q2 20182$18mn.a.n.a.
Q3 20182$8.1mn.a.n.a.
Q4 20181$5.7mn.a.n.a.
Q1 20191$5.2mn.a.n.a.
Q2 20192$4.7mn.a.n.a.
Q3 20191$5.2mn.a.n.a.
Q4 20191$5.7mn.a.n.a.
Q1 20201$4.8mn.a.n.a.
Q1 20211$10mn.a.n.a.
Q2 20211$19mn.a.n.a.
Q4 20211$21mn.a.n.a.
Q1 20221$25mn.a.n.a.
Q2 20221$18mn.a.n.a.
Q3 20221$13mn.a.n.a.
Q1 20231$388kn.a.n.a.
Q2 20231$391kn.a.n.a.
Q3 20231$6.0mn.a.n.a.
Q4 20233$13m21
Q1 20241$5.9m10
Q2 20242$7.5m20
Q3 20241$3.1m10
Q4 20241$3.8m10
Q1 20252$4.4m11
Q2 20252$3.9m11
Q3 20253$34m21
Q4 20252$5.6m169
Q1 20262$5.4m1113
Q2 20262$6.0m1111

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ANGO and LLY →ANGO and JNJ →ANGO and VRTX →Choose a stock to compare with ANGO →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ANGO, latest filings →Back to the 13F Explorer →